Investigational Drug Details
| Drug ID: | D521 |
| Drug Name: | BMS-986171 |
| Synonyms: | PEGylated FGF21; BMS986171 |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | Fibroblast growth factor replacements |
| Therapeutic Category: | Antifibrotics; Fibroblast growth factors; Hepatoprotectants |
| Clinical Trial Progress: | Phase 1 completed (NCT02538874) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0605 | NCT02538874 | Phase 1 | Not recruiting | No Results Available | 21/08/2015 | 16 December 2017 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|